Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib vs Dexamethasone with Remdesivir in Diabetic COVID-19 Patients
NCT04970719Phase 3Withdrawn
- Start
- Jul 2021
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of baricitinib in COVID-19 pneumonia. Planned start Jul 2021; status: withdrawn.
02
Drugs
baricitinib
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04970719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04970719.